Merck KGaA Archives - Page 8 of 8 -

NICE rejects German Merck’s Erbitux, unsure of effectiveness.

NICE rejects head and neck cancer drug once again

https://pharmaphorum.com/news/nice-rejects-head-neck-cancer-drug/

Nairobi funding doubled to $30,000.

Merck seeks wearables for next digital health accelerator

https://pharmaphorum.com/news/merck-seeks-wearables-next-digital-health-accelerator-ups-nairobi-funding/

Swiss biotech looks to combine small molecule drug with immunotherapy.

Debiopharm teams up with Merck KGaA and Pfizer in lung cancer

https://pharmaphorum.com/news/debiopharm-teams-merck-kgaa-pfizer-lung-cancer/

Anglo-Belgian biotech will continue clinical development.

Apitope to develop MS drug, Merck KGaA tie-up ends

https://pharmaphorum.com/news/apitope-develop-ms-drug-merck-kgaa-tie-ends/

Merck KGaA